FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Journal of veterinary internal medicine2023; 37(6); 2544-2551; doi: 10.1111/jvim.16914

Effects of phenylbutazone, firocoxib, and dipyrone on the diuretic response to furosemide in horses.

Abstract: Treatment with phenylbutazone (nonselective COX inhibitor) decreases the diuretic and natriuretic effects of furosemide by nearly 30% but the effects of COX-2 specific inhibitors (firocoxib) and atypical NSAIDs (dipyrone) are unknown. Objective: Furosemide-induced diuresis after pretreatment with firocoxib or dipyrone is diminished to a lesser extent than after pretreatment with phenylbutazone. Methods: Eight healthy mares. Methods: Each mare received 4 treatments in a prospective experimental crossover study using a replicated 4 × 4 Latin Square design: furosemide alone (FU), furosemide and phenylbutazone (PB), furosemide and firocoxib (FX), and furosemide and dipyrone (DP). After 24 hours of NSAID treatment at recommended dosages, ureteral catheters were placed for continual urine collection. After a 30-minute baseline collection period, furosemide (1.0 mg/kg, IV) was administered, and urine and blood samples were collected for 4 hours. Data were assessed by repeated measures ANOVA. Results: Four-hour urine volume was (mean ± SD) ~25% less (P < .001) after pretreatment with all NSAIDs (PB 19.1 ± 2.1 mL/kg, FX 17.7 ± 3.5 mL/kg, DP 19.1 ± 3.9 mL/kg), as compared to FU (23.4 ± 5.1 mL/kg) (P < .001), but there were no differences between PB, FX, or DP. Interindividual variability in furosemide diuresis after pretreatment with different NSAIDs was observed. Conclusions: Though COX-2 selective NSAIDs and dipyrone might have less severe or fever gastrointestinal adverse effects in horses, our data suggest minimal differences in effects on furosemide-induced diuresis, and possibly, risk of nephrotoxicosis.
© 2023 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.
Get Full Text
Publication Date: 2023-10-26 PubMed ID: 37882246PubMed Central: PMC10658499DOI: 10.1111/jvim.16914Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper investigates the impact of various nonsteroidal anti-inflammatory drugs (NSAIDs) – phenylbutazone, firocoxib, and dipyrone – on the diuretic effects of furosemide in horses. The study finds that all three NSAIDs reduce the diuretic effect of furosemide, but there is little difference between the individual effects of these three drugs.

Objective and Methods

  • The study aims to understand how firocoxib (a COX-2 specific inhibitor) and dipyrone (a variant of NSAID) diminish the diuretic effects of furosemide compared to phenylbutazone (a nonselective COX inhibitor).
  • In a prospective experimental crossover study, the researchers employed a replicated 4×4 Latin Square design to test four different treatments on eight healthy mares.
  • The four treatments include furosemide alone, furosemide and phenylbutazone, furosemide and firocoxib, and furosemide and dipyrone.
  • After 24 hours of NSAID treatment at the standard dosages, tubes were placed in the mares’ ureters to continuously collect urine.
  • Furosemide was then administered and urine and blood samples were collected for the following four hours.
  • The data were analyzed using repeated measures ANOVA.

Results

  • The urine volume of the mares over four hours was approximately 25% less after pretreatment with any of the NSAIDs compared to the administration of furosemide alone.
  • However, there were no significant differences observed in the diuretic effects of the three NSAIDs used.
  • The study also observed variability in the diuretic response to furosemide post NSAID pretreatment between individual horses.

Conclusion

  • Despite the potential for COX-2 selective NSAIDs and dipyrone to have fewer or less severe gastrointestinal side effects in horses, this study’s data suggest that their impact on furosemide-induced diuresis (and by association, the risk of kidney damage) is largely similar.
  • Therefore, using these NSAIDs in conjunction with furosemide does not significantly alter the diuretic response in horses compared to using phenylbutazone.

Cite This Article

APA
White JM, Colbath AC, Schott HC. (2023). Effects of phenylbutazone, firocoxib, and dipyrone on the diuretic response to furosemide in horses. J Vet Intern Med, 37(6), 2544-2551. https://doi.org/10.1111/jvim.16914

Publication

Journal of veterinary internal medicine
ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 37
Issue: 6
Pages: 2544-2551

Researcher Affiliations

White, Julianne M
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.
Colbath, Aimee C
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.
Schott, Harold C
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.

MeSH Terms

  • Animals
  • Horses
  • Female
  • Diuretics / pharmacology
  • Furosemide / pharmacology
  • Dipyrone / pharmacology
  • Cross-Over Studies
  • Cyclooxygenase 2
  • Prospective Studies
  • Phenylbutazone / pharmacology
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology

Grant Funding

  • 25532 / American College of Veterinary Internal Medicine
  • 6119824524 / Michigan State University College of Veterinary Medicine

Conflict of Interest Statement

Authors declare no conflict of interest.

References

This article includes 27 references
  1. MacAllister CG, Morgan SJ, Borne AT, Pollet RA. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.. J Am Vet Med Assoc 1993;202:71‐77.
    pubmed: 8420909
  2. Cheng HF, Harris RC. Cyclooxygenases, the kidney, and hypertension.. Hypertension 2004;43:525‐530.
    pubmed: 14732722
  3. Nørregaard R, Kwon TH, Frøkiær J. Physiology and pathophysiology of cyclooxygenase‐2 and prostaglandin E2 in the kidney.. Kidney Res Clin Pract 2015;34:194‐200.
    pmc: PMC4688592pubmed: 26779421
  4. Li Y, Wei Y, Zheng F, Guan Y, Zhang X. Prostaglandin E2 in the regulation of water transport in renal collecting ducts.. Int J Mol Sci 2017;18:2539.
    pmc: PMC5751142pubmed: 29186911
  5. Hinchcliff KW, Muir WW. Pharmacology of furosemide in the horse: a review.. J Vet Intern Med 1991;5:211‐218.
    pubmed: 1941755
  6. Huang X, Dorhout Mees E, Vos P, Hamza S, Braam B. Everything we always wanted to know about furosemide but were afraid to ask.. Am J Physiol Renal Physiol 2016;310:F958‐F971.
    pubmed: 26911852
  7. Mann B, Hartner A, Jensen BL, Kammerl M, Krämer BK, Kurtz A. Furosemide stimulates macula densa cyclooxygenase‐2 expression in rats.. Kidney Int 2001;59:62‐68.
    pubmed: 11135058
  8. Hinchcliff KW, McKeever KH, Muir WW. Pharmacologic interaction of furosemide and phenylbutazone in horses.. Am J Vet Res 1995;56:1206‐1212.
    pubmed: 7486400
  9. Dyke TM, Hinchcliff KW, Sams RA. Attenuation by phenylbutazone of the renal effects and excretion of frusemide in horses.. Equine Vet J 1999;31:289‐295.
    pubmed: 10454086
  10. Raidal SL, Hughes KJ, Charman AL, Nielsen SG, Phillips JK, Noble GK. Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses.. Am J Vet Res 2014;75:668‐679.
    pubmed: 24959734
  11. Doucet MY, Bertone AL, Hendrickson D. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.. J Am Vet Med Assoc 2008;232:91‐97.
    pubmed: 18167116
  12. Bindu S, Mazumder S, Bandyopadhyay U. Non‐steroidal anti‐inflammatory drugs (NSAIDs) and organ damage: a current perspective.. Biochem Pharmacol 2020;180:114147.
    pmc: PMC7347500pubmed: 32653589
  13. Wan EYF, Yu EYT, Chan L. Comparative risks of nonsteroidal anti‐inflammatory drugs on CKD.. Clin J Am Soc Nephrol 2021;16:898‐907.
    pmc: PMC8216605pubmed: 33910887
  14. Pelligand L, Suemanotham N, King JN. Effect of cyclooxygenase (COX)‐1 and COX‐2 inhibition on furosemide‐induced renal responses and isoform immunolocalization in the healthy cat kidney.. BMC Vet Res 2015;11:296.
    pmc: PMC4669647pubmed: 26634699
  15. Kose F, Besen A, Paydas S. Effects of selective COX‐2 inhibitor, rofecoxib, alone or combination with furosemide on renal functions and renal COX‐2 expression in rats.. Clin Exp Nephrol 2010;14:22‐27.
    pubmed: 19789943
  16. Morresey PR, White GW, Poole HM, Hu T, Yin M, Sundman EA. Randomized blinded controlled trial of dipyrone as a treatment for pyrexia in horses.. Am J Vet Res 2019;80:294‐299.
    pubmed: 30801213
  17. Stueber T, Buessecker L, Leffler A, Gillmann HJ. The use of dipyrone in the ICU is associated with acute kidney injury.. Eur J Anaesthesiol 2017;34:673‐680.
    pubmed: 28306590
  18. Schott HC, Hodgson DR, Bayly WM. Ureteral catheterisation in the horse.. Equine Vet Educ 1990;2:140‐143.
  19. Freestone JF, Carlson GP, Harrold DR. Influence of furosemide treatment on fluid and electrolyte balance in horses.. Am J Vet Res 1988;49:1899‐1902.
    pubmed: 3247914
  20. Hinchcliff KW, McKeever KH, Muir WW 3rd. Furosemide‐induced changes in plasma and blood volume of horses.. J Vet Pharmacol Ther 1991;14:411‐417.
    pubmed: 1774817
  21. Forro M, Lindinger MI. Frusemide results in an extracellular to intracellular fluid shift in horses.. Equine Vet J Suppl 2006;36:245‐253.
    pubmed: 17402426
  22. Castrop H, Schießl IM. Physiology and pathophysiology of the renal Na‐K‐2Cl cotransporter (NKCC2).. Am J Physiol Renal Physiol 2014;307:F991‐F1002.
    pubmed: 25186299
  23. Katayama S, Attallah AA, Stahl RA, Bloch DL, Lee JB. Mechanism of furosemide‐induced natriuresis by direct stimulation of renal prostaglandin E2.. Am J Physiol 1984;247:F555‐F5561.
    pubmed: 6594069
  24. Miyanoshita A, Terada M, Endou H. Furosemide directly stimulates prostaglandin E2 production in the thick ascending limb of Henle's loop.. J Pharmacol Exp Ther 1989;251:1155‐1159.
    pubmed: 2600809
  25. Kinter LB, Huffman WF, Stassen FL. Antagonists of the antidiuretic activity of vasopressin.. Am J Physiol 1988;254:F165‐F177.
    pubmed: 2964201
  26. Kammerl MC, Nüsing RM, Richthammer W, Krämer BK, Kurtz A. Inhibition of COX‐2 counteracts the effects of diuretics in rats.. Kidney Int 2001;60:1684‐1691.
    pubmed: 11703585
  27. Deen P, Boone M, Schweer H. A vasopressin‐induced change in prostaglandin receptor subtype expression explains the differential effect of PGE2 on AQP2 expression.. Front Physiol 2022;12:787598.
    pmc: PMC8814457pubmed: 35126177

Citations

This article has been cited 2 times.
  1. Zhou K, Dong Z, Zhou X, Zhai B, Li B, Zhang J, Cheng F. The Prevalence of Gastric Ulcer Syndrome in 395 Horses in Jiangyin City, China, Jiangsu Province. Animals (Basel) 2024 Dec 17;14(24).
    doi: 10.3390/ani14243636pubmed: 39765539google scholar: lookup
  2. van Galen G, Divers TJ, Savage V, Schott HC 2nd, Siwinska N. ECEIM consensus statement on equine kidney disease. J Vet Intern Med 2024 Jul-Aug;38(4):2008-2025.
    doi: 10.1111/jvim.17101pubmed: 38801172google scholar: lookup
Subscribe to our newsletter
Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.